Real-time enrollment status for this essential thrombocythemia clinical trial
Current Status
Recruiting
Checked: September 20, 2026 at 7:53 PM UTC
| NCT Number | NCT07623200 |
| Recruiting Status | Recruiting |
| Condition | Essential Thrombocythemia |
| Phase | PHASE3 |
| Target Enrollment | 426 participants |
| Active Locations | 40 sites in the US |
| Sponsor | Incyte Corporation |
| Last Updated on CT.gov | September 14, 2026 (6 days ago) |
As of September 20, 2026: Clinical trial NCT07623200 is currently recruiting participants. This phase3 study for essential thrombocythemia is actively seeking new participants at 40 locations across the United States. The study is sponsored by Incyte Corporation. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07623200 is actively recruiting participants as of September 20, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 40 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07623200 was last updated 6 days ago (September 14, 2026). HelloStudys verifies this status automatically.